Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.44 USD | -0.45% | -2.63% | -34.42% |
06-03 | UniQure Shares Rise After US FDA Grants Regenerative Medicine Advanced Designation for Huntington's Treatment | MT |
06-03 | UniQure's AMT-130 Gets FDA RMAT Designation in Huntington's Disease | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.42% | 217M | |
+16.91% | 122B | |
+21.64% | 116B | |
+22.18% | 27.03B | |
-21.36% | 20.36B | |
-16.89% | 16.43B | |
-18.38% | 15.91B | |
-44.74% | 15.6B | |
+62.80% | 14.94B | |
+2.67% | 13.59B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- UniQure Says It Is Set to Receive $100 Million Milestone Payment for First US Commercial Sale of Hemgenix